Key points are not available for this paper at this time.
Muscle-invasive urothelial carcinoma is an aggressive disease with high rates of relapse. Whether pembrolizumab as adjuvant therapy would be effective in patients with high-risk muscle-invasive urothelial carcinoma after radical surgery is unknown.
Building similarity graph...
Analyzing shared references across papers
Loading...
Andrea B. Apolo
National Institutes of Health
Karla V. Ballman
Rutgers, The State University of New Jersey
Guru Sonpavde
Harvard University
New England Journal of Medicine
National Institutes of Health
National Cancer Institute
Center for Cancer Research
Building similarity graph...
Analyzing shared references across papers
Loading...
Apolo et al. (Sat,) studied this question.
synapsesocial.com/papers/68e587feb6db643587524985 — DOI: https://doi.org/10.1056/nejmoa2401726